View in EDS

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.

Saved in:
Bibliographic Details
Title: Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
Authors: Koch MS; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Zdioruk M; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Nowicki MO; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Griffith AM; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Aguilar E; Candel Therapeutics, Needham, Massachusetts, USA., Aguilar LK; Candel Therapeutics, Needham, Massachusetts, USA., Guzik BW; Candel Therapeutics, Needham, Massachusetts, USA., Barone F; Candel Therapeutics, Needham, Massachusetts, USA., Tak PP; Candel Therapeutics, Needham, Massachusetts, USA., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Tuebingen, Germany., Lederer JA; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Lawler S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA slawler@bwh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35017150
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koch+MS%22">Koch MS</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zdioruk+M%22">Zdioruk M</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Nowicki+MO%22">Nowicki MO</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Griffith+AM%22">Griffith AM</searchLink>; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Aguilar+E%22">Aguilar E</searchLink>; Candel Therapeutics, Needham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Aguilar+LK%22">Aguilar LK</searchLink>; Candel Therapeutics, Needham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Guzik+BW%22">Guzik BW</searchLink>; Candel Therapeutics, Needham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Barone+F%22">Barone F</searchLink>; Candel Therapeutics, Needham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Tak+PP%22">Tak PP</searchLink>; Candel Therapeutics, Needham, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Tabatabai+G%22">Tabatabai G</searchLink>; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Lederer+JA%22">Lederer JA</searchLink>; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Chiocca+EA%22">Chiocca EA</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lawler+S%22">Lawler S</searchLink>; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA slawler@bwh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35017150
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2021-003368
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koch MS
      – PersonEntity:
          Name:
            NameFull: Zdioruk M
      – PersonEntity:
          Name:
            NameFull: Nowicki MO
      – PersonEntity:
          Name:
            NameFull: Griffith AM
      – PersonEntity:
          Name:
            NameFull: Aguilar E
      – PersonEntity:
          Name:
            NameFull: Aguilar LK
      – PersonEntity:
          Name:
            NameFull: Guzik BW
      – PersonEntity:
          Name:
            NameFull: Barone F
      – PersonEntity:
          Name:
            NameFull: Tak PP
      – PersonEntity:
          Name:
            NameFull: Tabatabai G
      – PersonEntity:
          Name:
            NameFull: Lederer JA
      – PersonEntity:
          Name:
            NameFull: Chiocca EA
      – PersonEntity:
          Name:
            NameFull: Lawler S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022 Jan
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1